US NYSE stock alert

USA

End of Day Alert: Johnson and Johnson increases 1.1% - outperforming 91% of stocks 20 September 2018 17:53 EDT

NEWS BITES - NORTH AMERICA

Johnson and Johnson, NYSE's largest pharmaceuticals company by market capitalisation, has increased $US1.52 (or 1.1%) today to trade at $US141.98 and has outperformed 91% of the market in the past three months. A price rise combined with a high relative strength is a bullish signal. Compared with the S&P 500 Index which rose 22.8 points (or 0.8%) in the day, this represented a relative price increase of 0.3%.

Technical indicators complementing today's significant uptrend:

+ The positive 2.5 MACD (Moving Average Convergence Divergence) indicator suggests a bullish signal.

+ The 2.3% discount to 12-month high of $US145.32 against the 20.5% premium to 12-month low of $US117.83 suggests the stock continues to push for new highs.

+ The price increased 1.5% in the last week and climbed 4.4% in the last month.

Fundamental measures by comparison with the sector average [in brackets] indicate:

Undervaluation:

+ Price/Earnings of 24.2 [30.5]

+ Return on Capital Employed 14.7% [8.6%]

Other Bullish Signals include:

+ Interest cover is less leveraged at 19.9 times.

+ Net profit margin has averaged 15.6% in the last 3 years. This is considered superior and suggests a high margin of safety.

+ The Brand Value represents 2.0% of the estimated Enterprise Value of $US415.4 billion.

Note

Bearish Signals:

Tobin's Q Ratio is 2.4. Compared with the rest of the market the stock is overvalued and ranks in the bottom quartile of stocks by value of Q Ratio.

As per the Du Pont analysis, Return on Equity is less than stellar at 2.2%. Also, this has deteriorated from 23.5% last year.

Fundamental measures by comparison with the sector average [in brackets] indicate:

Overvaluation:

Return on Equity 2.2% [17.2%]

Return on Assets 0.8% [6.5%]

RECENT ALERTS

End of Day Alert: Johnson and Johnson decreases 0.1%

19 September 2018 17:54 EDT

Johnson and Johnson, NYSE's largest pharmaceuticals company by market capitalisation, traded on volume of 0.8 times average today while the price decreased 8.0c (or 0.1%) to trade at $US140.46. Compared with the S&P 500 Index which rose 3.6 points (or 0.1%) in the day, this represented a relative price change of -0.2%.

Afternoon Alert: Johnson and Johnson in 3rd consecutive rise, nears an 11-month high

19 September 2018 12:39 EDT

Johnson & Johnson (NYSE:JNJ) extended its gains Wednesday, rising an additional 10.0c (or 0.1%) to trade at $US140.64. The stock increased 0.34% on Monday and 0.41% on Tuesday bringing its 3-day rise to 0.8%. It is now approaching its 231-day high of $US140.99.

Johnson & Johnson (N:JNJ)

ISIN: US4781601046

PermID: 4295904341

CIK: 200406

CUSIP: 478160104

Source: www.BuySellSignals.com